Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Has announcements × Eflornithine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 1

Interventions

toripalimab 1 sodium thiosulfate 1 naxitamab 1 Vincristine 1 Rituximab 1 Methotrexate 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Eflornithine 1 Drug Therapy 1 Doxorubicin 1 Daunorubicin 1 Cytarabine 1 Cyclophosphamide 1 Cisplatin 1 Abatacept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02395666 2024-08-06

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Milton S. Hershey Medical Center

Phase 2 Completed

140 enrolled 14 charts 1 FDA

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡